Sign up to save your podcasts
Or
Share Genetic variation in CRHR1 is associated with short-term respiratory response to corticosteroids...
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Genetic variation in CRHR1 is associated with short-term respiratory response to corticosteroids...
Bronchopulmonary Dysplasia (BPD) is a form of Chronic lung disease and results from extreme pre-term birth. Systemic corticosteroid therapy is used postnatally to reduce the severity of BPD, however there is a large range in the phenotypic response to this treatment. In this episode, we speak to Tamorah Lewis, a neonatologist at Children's Mercy Hospital in Kansas City, who aimed to identify pharmacogenetic variants associated with the clinical response to systemic corticosteroid treatment.
Related article:
https://www.nature.com/articles/s41390-018-0235-1
View all episodes
By Springer NatureBronchopulmonary Dysplasia (BPD) is a form of Chronic lung disease and results from extreme pre-term birth. Systemic corticosteroid therapy is used postnatally to reduce the severity of BPD, however there is a large range in the phenotypic response to this treatment. In this episode, we speak to Tamorah Lewis, a neonatologist at Children's Mercy Hospital in Kansas City, who aimed to identify pharmacogenetic variants associated with the clinical response to systemic corticosteroid treatment.
Related article:
https://www.nature.com/articles/s41390-018-0235-1